You have 9 free searches left this month | for more free features.

stage III lymphoepithelioma of the nasopharynx

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma

Completed
  • Stage II Lymphoepithelioma of the Nasopharynx
  • +5 more
  • Stanford, California
    Stanford University Hospitals and Clinics
Mar 10, 2021

Head Neck Cancer Trial in Nashville (biologic sample preservation procedure, medical chart review)

Recruiting
  • Head and Neck Cancer
  • biologic sample preservation procedure
  • medical chart review
  • Nashville, Tennessee
  • +3 more
Oct 28, 2022

Head Neck Cancer Trial in Singapore (carboplatin,, cisplatin, gemcitabine HCl)

Active, not recruiting
  • Head and Neck Cancer
  • Singapore, Singapore
    National Cancer Centre - Singapore
Sep 27, 2022

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Anorexia, Cachexia, Head Neck Cancer Trial in Winston-Salem (megestrol acetate, quality-of-life assessment)

Completed
  • Anorexia
  • +3 more
  • megestrol acetate
  • quality-of-life assessment
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center at Wake Forest University
Sep 7, 2021

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • erlotinib hydrochloride
  • +10 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +57 more
  • placebo
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 18, 2020

Head Neck Cancer, Mucositis Oral, Radiation Toxicity Trial in San Francisco (sargramostim, oral salt and soda mouthwash)

Completed
  • Head and Neck Cancer
  • +3 more
  • sargramostim
  • oral salt and soda mouthwash
  • San Francisco, California
    University of California, San Francisco
Jul 9, 2021

Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

Not yet recruiting
  • Papillary Renal Cell Carcinoma
  • (no location specified)
Nov 24, 2023

Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)

Completed
  • Lymphoma
  • bleomycin sulfate
  • +12 more
  • Garran, Australian Capital Territory, Australia
  • +139 more
Dec 19, 2022

Colorectal Cancer Trial in Taipei (Colectomy with NOSE procedure)

Recruiting
  • Colorectal Cancer
  • Colectomy with NOSE procedure
  • Taipei, Taiwan
    National Taiwan University Hospital
Jul 23, 2023

Locally Advanced Rectal Cancer, Older People Trial in Belgium (radiation, drug, procedure, combination product)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Older People
  • Short course radiotherapy
  • +3 more
  • Edegem, Antwerpen, Belgium
  • +12 more
Sep 18, 2023

Nasopharyngeal Carcinoma Trial in Hong Kong (Trans-oral magnifying endoscopy with NBI)

Recruiting
  • Nasopharyngeal Carcinoma
  • Trans-oral magnifying endoscopy with NBI
  • Hong Kong, Hong Kong
    Prince of Wales Hospital
Aug 15, 2022

Resectable Melanoma, Melanoma Stage III, Melanoma (Skin) Trial in Belarus, Russian Federation (BCD-217, anti-PD1, Excision of

Recruiting
  • Resectable Melanoma
  • +2 more
  • BCD-217
  • +3 more
  • Lesnoy, Belarus
  • +35 more
Feb 21, 2023

Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

Not yet recruiting
  • Ovarian Cancer
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023

Nivolumab in Treatment of Early Stage Esophageal or

Not yet recruiting
  • Esophageal Carcinoma
  • Gastroesophageal Junction Carcinoma
    • Louisville, Kentucky
    • +2 more
    Mar 21, 2023

    Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

    Not yet recruiting
    • Recurrent Glioblastoma
    • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
    • (no location specified)
    Apr 4, 2023

    Intraoral Measurement of Pressure in Preterm Infants

    Active, not recruiting
    • Preterm Infants
    • non-invasive ventilation
    • Göttingen, Germany
      University Medicine Göttingen
    Nov 2, 2022

    ResiduAl Cancer With Liquid Biopsy Evaluation

    Recruiting
    • Bladder Carcinoma
    • +14 more
    • Guardant Reveal
    • Redwood City, California
      Redwood City
    Sep 7, 2022

    Head Neck Cancer, Lung Cancer, Ovarian Cancer Trial in Vancouver, Hamilton, Toronto (cisplatin, lurtotecan liposome)

    Completed
    • Head and Neck Cancer
    • +3 more
    • Vancouver, British Columbia, Canada
    • +2 more
    Apr 2, 2020

    Ovarian Cancer Trial in Goyang (Cisplatin)

    Not yet recruiting
    • Ovarian Cancer
    • Goyang, Gyeonggi, Korea, Republic of
      National Cancer Center
    Apr 24, 2023

    Circulating Tumor Cells for Treatment Response of Lung Cancer

    Recruiting
    • Lung Neoplasm
    • Lung Tumor Resection
    • San Antonio, Texas
      UT Health San Antonio, M.D. Anderson Cancer Center
    Jan 23, 2023

    Breast Cancer Female Trial (Pyrotinib and Trastuzumab)

    Not yet recruiting
    • Breast Cancer Female
    • Pyrotinib and Trastuzumab
    • (no location specified)
    Sep 11, 2023